Larvol Delta - MEK-inhibitors-as-novel-hosttargeted-antivirals-with-a-dualbenefit-mode-of-action-against-hyperinflammatory-respiratory-viral-diseases

zapnometinib (ATR-002) - Atriva Therap

http://www.ncbi.nlm.nih.gov/pubmed/36841033

Feb 26, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next